|Bid||57.71 x 1800|
|Ask||58.34 x 1800|
|Day's range||57.57 - 58.60|
|52-week range||46.48 - 64.94|
|Beta (5Y monthly)||0.21|
|PE ratio (TTM)||38.52|
|Forward dividend & yield||1.40 (2.40%)|
|Ex-dividend date||25 Feb 2021|
|1y target est||63.60|
(Bloomberg) -- Brazil reached 500,000 deaths from Covid-19 on Saturday, a toll second only to the U.S. As the milestone was officially passed, thousands protested in major cities against President Jair Bolsonaro and his handling of the pandemic.U.S infections have fallen to the level of the first lockdowns in March 2020, though President Joe Biden warned of a “deadly threat” from the highly-transmissible delta variant first found in India and now expected to become the dominant strain in the U.S
Biogen has had its breakthrough Alzheimer's drug approved and AstraZeneca has several exciting drugs in development. Are these pharma stocks buys for me? The post Pharma stock investing: Biogen vs AstraZeneca appeared first on The Motley Fool UK.
This Fool highlights one FTSE 100 and one FTSE 250 stock that he would buy for his portfolio for large and mid-cap growth. The post 1 FTSE 100 and 1 FTSE 250 stock to buy appeared first on The Motley Fool UK.